(Q36138183)
Statements
Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways (English)
Ligang Zhou
Gregory M Sutton
Laura J Oksanen
Zoe D Thornton-Jones
Chen-Yu Yueh
Joel K Elmquist
Andrew A Butler